Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00668213
What this trial is testing

Antioxidant Systems and Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Vanderbilt University 143
Large-scale testing (Phase 3)Study completedNCT02374060
What this trial is testing

PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial

Who this might be right for
Macular EdemaUveitis
JHSPH Center for Clinical Trials 192
Testing effectiveness (Phase 2)Ended earlyNCT00768040
What this trial is testing

Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 39
Not applicableWithdrawnNCT02457026
What this trial is testing

Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Duke University
Large-scale testing (Phase 3)Ended earlyNCT02247479
What this trial is testing

A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Hoffmann-La Roche 906
Not applicableUnknownNCT03944070
What this trial is testing

Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery

Who this might be right for
Wet Macular DegenerationCataract Extraction
Ophthalmica Eye Institute 16
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Not applicableStudy completedNCT05988827
What this trial is testing

Effect of Minimizing Light Exposure Intensity on Macular Function After Cataract Surgery in Patients With Early or Intermediate AMD

Who this might be right for
Macular Degeneration, Age RelatedCataract
Elsan 42
Testing effectiveness (Phase 2)Ended earlyNCT04566445
What this trial is testing

HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Who this might be right for
Dry Age-related Macular Degeneration
Gyroscope Therapeutics Limited 255
Not applicableStudy completedNCT06495203
What this trial is testing

Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO

Who this might be right for
Neovascular Age-related Macular DegenerationRetinal Vein Occlusion
Bayer 1,350
Not applicableLooking for participantsNCT06619405
What this trial is testing

AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance

Who this might be right for
Age-Related Macular Degeneration
Duke University 100
Testing effectiveness (Phase 2)Study completedNCT03364153
What this trial is testing

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

Who this might be right for
Stargardt's Macular Dystrophy
Astellas Pharma Global Development, Inc. 121
Large-scale testing (Phase 3)Active Not RecruitingNCT05112861
What this trial is testing

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 120
Post-approval studies (Phase 4)Study completedNCT02944227
What this trial is testing

Efficacy of Fixed Monthly Dosing of Ranibizumab in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Seoul National University Hospital 20
Not applicableStudy completedNCT01712841
What this trial is testing

Non-exudative Age-related Macular Degeneration

Who this might be right for
Non-exudative Age-related Macular Degeneration
Oregon Health and Science University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06707753
What this trial is testing

Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. 21
Not applicableStudy completedNCT00465400
What this trial is testing

Oxidative Stress in Patients With Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
University Hospital, Basel, Switzerland 12
Testing effectiveness (Phase 2)Study completedNCT01226628
What this trial is testing

A Safety Study of CNTO 2476 in Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Janssen Research & Development, LLC 39
Not applicableUnknownNCT02081339
What this trial is testing

Cohort Study of the Clinical Course of Macular Diseases in Japanese

Who this might be right for
Macular Disease
Kyoto University, Graduate School of Medicine 1,000
Not applicableStudy completedNCT04779411
What this trial is testing

Online Validation of Dietary Intake Food Frequency Questionnaire Over Four Weeks, and Electronic Device Use Questionnaire Over Eight Weeks.

Who this might be right for
Lutein and Zeaxanthin Dietary IntakeAge Related Macular DegenerationBlue Light Exposure+1 more
The University of Queensland 183
Next Page